Risperdal, a medication commonly prescribed for ADHD, autism, and bipolar disorder, has been linked to gynecomastia in adolescent boys. Legal advertisements are targeting families whose sons developed enlarged breasts after taking the drug, offering financial compensation from the manufacturer. The side effect has led to significant litigation against the pharmaceutical companies producing the antipsychotic medication.
